Navigation Links
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
Date:2/27/2012

/p>

7,217

 

1,147Others

219

 

(411)

 

(65)

 

1,109

 

(86)

 

(14)Total other income, net

1,838

 

5,902

 

938

 

6,078

 

13,385

 

2,126Income before income tax

36,679

 

37,426

 

5,948

 

93,468

 

113,386

 

18,015Income tax (expense)/ credit

(8,840)

 

4,273

 

679

 

(23,062)

 

(3,037)

 

(483)Net income27,839

 

41,699

 

6,627

 

70,406

 

110,349

 

17,532Income attributable to noncontrolling

 

 

 

 

 

 

 

 

 

 

   interests

(1,964)

 

(2,229)

 

(354)

 

(4,962)

 

(7,608)

 

(1,209)Net income attributable to 

 

 

 

 

 

 

 

 

 

  shareholders25,875

 

39,470

 

6,273

 

65,444

 

102,741

 

16,323 

 

 

 

 

 

 

 

 

 

 

 Net income per share: 

 '/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
3. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
4. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
5. China Biologic Products Announces Second Quarter 2008 Results Conference Call
6. China Medicine Announces Strong Second Quarter 2008 Results
7. China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee
8. China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results
9. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
10. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
11. China Biologic Products Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... on December 22, 2014, thereby completing the U.S. ... the acquisition of the Company by Merck KGaA, ... satisfies another condition to closing the transaction, which ...
(Date:12/22/2014)... , Dec. 22, 2014   ... a developer of pathogen-specific therapies for serious ... protecting the microbiome, today announced positive topline ... 1a clinical trial of SYN-004, the Company,s ... of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/19/2014)... Tigard, OR and Hershey, PA (PRWEB) December 19, ... (OTC Pink: BJCT), a leading developer and manufacturer ... has entered into an agreement with Immunomic Therapeutics, ... Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ ... receives an option for an exclusive Worldwide license ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... Oct. 1 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... preclinical results for its CYT387 JAK1/JAK2 inhibitor program ... and selectivity profile which may provide significant clinical ... Phase I/II clinical study at Mayo Clinic in ...
... CITY, Oct. 1 /PRNewswire-FirstCall/ - Medicago U.S.A. Inc., ... MDG), a biotechnology company focused on developing highly ... technologies and Virus-Like Particles (VLPs), today announced that ... (D-NC) and U.S. Congressman David Price (D-NC), are ...
... (OTC Bulletin Board: BHRT ) a company ... cell therapies for the treatment of cardiovascular diseases, announced ... Seaside National Bank and Trust for a $980,000 loan ... with Bank of America. The loan is subject to ...
Cached Biology Technology:YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference 2YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference 3Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility 2Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility 3Bioheart, Inc. Announces Loan to be Assumed by Seaside 2Bioheart, Inc. Announces Loan to be Assumed by Seaside 3
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... pleasantly salty without adding more salt? Change the bread,s texture ... ACS, Journal of Agricultural and Food Chemistry that ... perceive bread as having saltier taste. The process could become ... risk factor for high blood pressure and heart disease. ...
... Every day, the human body produces new cells to regenerate ... this happens, the cells make copies of their DNA that ... process of copying the DNA, also called replication, is very ... DNA that are associated with malignant transformation or ageing. ...
... , Nov. 19, 2013 Dynasil Corporation of ... its contract research subsidiary, RMD Inc., has received four grants ... Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) ... continues to be on the cutting edge of new technologies," ...
Cached Biology News:Spanish scientists identify a new ancestral enzyme that facilitates DNA repair 2Dynasil's RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy 2Dynasil's RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy 3
Human RUNX2/CBFA1 MAb (Clone 232902)...
Lipid-rich bovine serum albumin for cell culture (1). It is chromatographically purified and has an IgG content 0.1% (w/w)....
normal rat IgM AF647...
GlutaMAX-I Supplement...
Biology Products: